TREM-1 mediates inflammatory injury and cardiac remodeling following myocardial infarction

Circulation Research

Volumn 116, Issue 11, 2015, Pages 1772-1782

  Boufenzer, Amir ^a   Lemarié, Jérémie ^a,c   Simon, Tabassome ^e,f   Derive, Marc ^a,g   Bouazza, Youcef ^a   Tran, Nguyen ^b   Maskali, Fatiha ^d   Groubatch, Frédérique ^b   Bonnin, Philippe ^h   Bastien, Claire ^d   Bruneval, Patrick ⁱ   Marie, Pierre Yves ^d   Cohen, Raphael ⁱ   Danchin, Nicolas ^j,k   Silvestre, Jean Sébastien ⁱ   Ait Oufella, Hafid ⁱ   Gibot, Sébastien ^a,c  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d CHU NANCY BRABOIS   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g INOTREM SA   (France)

^h Hôpital Lariboisière   (France)

ⁱ PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^j HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

Immune system; Infarction; Inflammation

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MONOCYTE CHEMOTACTIC PROTEIN 1; SYNTHETIC PEPTIDE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; PEPTIDE; TREM1 PROTEIN, HUMAN; TREM1 PROTEIN, MOUSE;

ACUTE HEART INFARCTION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; INNATE IMMUNITY; LEUKOCYTE MIGRATION INHIBITION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; MOUSE; MYOCARDITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RAT; REGULATORY MECHANISM; SURVIVAL RATE; UPREGULATION; ACUTE DISEASE; AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; C57BL MOUSE; CORONARY ARTERY DISEASE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HEART INFARCTION; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; WESTERN BLOTTING; WISTAR RAT;

ACUTE DISEASE; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CORONARY DISEASE; GENE EXPRESSION; HUMANS; INFLAMMATION; LEUKOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; PEPTIDES; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84938545763     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.305628     Document Type: Article

References (20)

1. Frangogiannis NG., Targeting The inflammatory response in healing myocardial infarcts. Curr Med Chem 2006; 13: 1877-1893.
2. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ., The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007; 204: 3037-3047. doi: 10.1084/jem.20070885.
3. Swirski FK, Nahrendorf M., Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013; 339: 161-166. doi: 10.1126/science.1230719.
4. Zouggari Y, Ait-Oufella H, Bonnin P, B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med 2013; 19: 1273-1280. doi: 10.1038/nm.3284.
5. Frangogiannis NG., The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 2014; 11: 255-265. doi: 10.1038/nrcardio.2014.28.
6. Bouchon A, Facchetti F, Weigand MA, Colonna M., TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410: 1103-1107. doi: 10.1038/35074114.
7. Gibot S, Kolopp-Sarda MN, Béné MC, Bollaert PE, Lozniewski A, Mory F, Levy B, Faure GC., A soluble form of The triggering receptor expressed on myeloid cells-1 modulates The inflammatory response in murine sepsis. J Exp Med 2004; 200: 1419-1426. doi: 10.1084/jem.20040708.
8. Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, Massin F, Max JP, Ford J, Alauzet C, Levy B, McVicar DW, Gibot S., Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol 2012; 188: 5585-5592. doi: 10.4049/jimmunol.1102674.
9. Derive M, Boufenzer A, Bouazza Y, Groubatch F, Alauzet C, Barraud D, Lozniewski A, Leroy P, Tran N, Gibot S., Effects of a TREM-like transcript 1-derived peptide during hypodynamic septic shock in pigs. Shock 2013; 39: 176-182. doi: 10.1097/SHK.0b013e31827bcdfb.
10. Derive M, Boufenzer A, Gibot S., Attenuation of responses to endotoxin by The triggering receptor expressed on myeloid cells-1 inhibitor LR12 in nonhuman primate. Anesthesiology 2014; 120: 935-942. doi: 10.1097/ALN.0000000000000078.
11. Weber B, Schuster S, Zysset D, TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. PLoS Pathog 2014; 10: e1003900. doi: 10.1371/journal.ppat.1003900.
12. Klesney-Tait J, Keck K, Li X, Gilfillan S, Otero K, Baruah S, Meyerholz DK, Varga SM, Knudson CJ, Moninger TO, Moreland J, Zabner J, Colonna M., Transepithelial migration of neutrophils into The lung requires TREM-1. J Clin Invest 2013; 123: 138-149. doi: 10.1172/JCI64181.
13. Kempf T, Zarbock A, Widera C, GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med 2011; 17: 581-588. doi: 10.1038/nm.2354.
14. Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L, French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009; 360: 363-375. doi: 10.1056/NEJMoa0808227.
15. Lim P, Moutereau S, Simon T, Gallet R, Probst V, Ferrieres J, Gueret P, Danchin N., Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from The French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]). Am J Cardiol 2013; 111: 31-37. doi: 10.1016/j.amjcard.2012.08.042.
16. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ., Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009; 325: 612-616. doi: 10.1126/science.1175202.
17. Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F, HALT-MI Investigators The effect of blockade of The CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: The results of The HALT-MI study. J Am Coll Cardiol 2002; 40: 1199-1204.
18. Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes D Jr, O'Neill WW, Todaro TG, Vahanian A, Van de Werf F., Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 2007; 297: 43-51.
19. Christia P, Frangogiannis NG., Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest 2013; 43: 986-995. doi: 10.1111/eci.12118.
20. Hofmann U, Beyersdorf N, Weirather J, Podolskaya A, Bauersachs J, Ertl G, Kerkau T, Frantz S., Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 2012; 125: 1652-1663. doi: 10.1161/CIRCULATIONAHA.111.044164.